Vascular endothelial growth factor as a biomarker for endostatin gene therapy (2013)
Source: Biomedicine & Pharmacotherapy. Unidade: FM
Subjects: NEOPLASIAS RENAIS (SECUNDÁRIO), CARCINOMA, METÁSTASE NEOPLÁSICA, NEOVASCULARIZAÇÃO PATOLÓGICA, BIOMARCADORES, TERAPIAS COMPLEMENTARES, ENDOTÉLIO VASCULAR
ABNT
BRAGA, Marina Souza et al. Vascular endothelial growth factor as a biomarker for endostatin gene therapy. Biomedicine & Pharmacotherapy, v. 67, n. 6, p. 511-515, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.biopha.2013.04.008. Acesso em: 16 nov. 2024.APA
Braga, M. S., Turaça, T. L., Foguer, K., Chaves, K. C. B., Pesquero, J. B., Chammas, R., et al. (2013). Vascular endothelial growth factor as a biomarker for endostatin gene therapy. Biomedicine & Pharmacotherapy, 67( 6), 511-515. doi:10.1016/j.biopha.2013.04.008NLM
Braga MS, Turaça TL, Foguer K, Chaves KCB, Pesquero JB, Chammas R, Schor N, Bellini MH. Vascular endothelial growth factor as a biomarker for endostatin gene therapy [Internet]. Biomedicine & Pharmacotherapy. 2013 ; 67( 6): 511-515.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.biopha.2013.04.008Vancouver
Braga MS, Turaça TL, Foguer K, Chaves KCB, Pesquero JB, Chammas R, Schor N, Bellini MH. Vascular endothelial growth factor as a biomarker for endostatin gene therapy [Internet]. Biomedicine & Pharmacotherapy. 2013 ; 67( 6): 511-515.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.biopha.2013.04.008